ADVANCED SYSTEMS FOR DISEASE DIAGNOSIS AND MANAGEMENT

1
ADVANCED SYSTEMS FOR DISEASE DIAGNOSIS AND
MANAGEMENT
Confidential, Smart Holograms 2005
2
THE COMPANY
3
BOARD OF DIRECTORS
FRANK F. CRAIG PHD MBA CHIEF EXEC. OFFICER Blue
Chip, Biotech Entrepreneur
PUNEET BHATIA MIF MBA CFA COMPANY DIRECTOR VC -
Partnerships UK
PROF. CHRIS LOWE PHD COMPANY DIRECTOR Academic
Entrepreneur
ANDREW WILLIAMS BA MA FCA CHIEF FINANCIAL
OFFICER Blue Chip and Biotech
PAUL RODGERS PHD CHAIRMAN Biotech Entrepreneur
MIKE POWELL PHD FRSC PRESIDENT SH INC. Blue Chip,
Biotech Entrepreneur
SHIMI SHAH BSC MPHIL COMPANY DIRECTOR VC -
Porton Capital
4
COMMERCIAL ACTIVITIES
5
COMPANY FINANCING CIRCA 16.7 M
6
INTELLECTUAL PROPERTY
SCIENCE IS PROTECTED BY 25 GRANTED/FILED PATENTS
BRANDS ARE PROTECTED BY 6 TRADEMARKS
7
UNIQUE TECHNOLOGY FEATURES
8
TRANS-INDUSTRY PLATFORM TECHNOLOGY
9
GLUCOSE SENSOR FOR DIABETICS
10
SMART GLUCOVIEWTM FORMATS
11
CONTACT LENS WITH HOLOGRAM
12
PROTOTYPE OPTICAL SUB-ASSEMBLY (EYE READER)
13
INFECTION CONTROL MARKET
14
NEW SLIMLINE PATHOTESTERTM
SAMPLE COLLECTION
SAMPLE CONCENTRATION
SAMPLE EXTRACTION (OPTIONAL)
SAMPLE PURIFICATION (OPTIONAL)
BIOCHEMICAL REACTIONS
AND SIGNAL DETECTION
ALL PERFORMED ON A SINGLE FORMAT -
NANOCARTRIDGETM
15
NANOCARTRIDGETM DESIGN
COMPARED TO CURRENT PRACTICES NANOCARTRIDGESTM
PERMIT

• USAGE OF 100-1000 FOLD
• LOWER SAMPLE
• COLLECTION AND
• REAGENT VOLUMES

• DETECTION TIMES TO BE
• DECREASED 10-20 FOLD

• ASSAY COSTS TO BE
• REDUCED BY 10-FOLD

16
UNIQUE FEATURES OF PATHOTESTERTM
17
MANUFACTURING
18
SUMMARY